latest posts
March 17, 2014
The importance of protein-protein interactions
This month, Dr. Claudio Dagostin spent a few hours with us at Intelligent Pharma. Dr. Dagostin is an expert from the University of Cambridge in protein-protein interactions and gave us an interesting talk about the role of this type of interaction in nature and in therapeutics. Definitively, working on disrupting protein-protein interactions is a cha...
January 21, 2014
Molecular Dynamics, from high performance computing to high throughput screening
There is a widespread consensus that the use of a rigid model of a protein target is highly limiting as does not take into account natural conformational variations of the protein and, in particular, the thermodynamics and kinetics of the binding process of a drug, which can be of a great importance in drug discovery. The computational methodology that allows ...
November 26, 2013
Molecular Modeling beyond Drug Discovery
Intelligent Pharma has historically focused all its activities on drug discovery. Our clients range from big pharmaceutical companies to small and virtual biotech, most of them focused on “red life sciences” or, in other words, focused on developing new drugs and treatments for human health.   However, since some years ago, we also det...